ROBERT J HURST
Allopathic & Osteopathic Physicians|Internal Medicine BLOOMINGDALE, IL NPI 1972579142
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine IL Novo Nordisk AS All categories
General Payments — all program years on this page
$1,011.33
- Category: General Payments
- Program years: PY2018–2024
- Record count: 52
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $134.71 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $134.71 | 7 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $36.07 | 2 |
| Otsuka America Pharmaceutical, Inc. | $25.12 | 1 |
| Lilly USA, LLC | $24.06 | 1 |
| Acerta Pharma LLC | $19.28 | 1 |
| Hikma Pharmaceuticals USA | $17.00 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $13.18 | 1 |
By program year
Records — PY2024 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1097175302 | Novo Nordisk Inc | $16.36 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1097332997 | Novo Nordisk Inc | $19.71 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1105337305 | AstraZeneca Pharmaceuticals LP | $19.28 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1118911199 | Otsuka America Pharmaceutical, Inc. | $25.12 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1127506660 | Hikma Pharmaceuticals USA | $17.00 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1135366978 | Lilly USA, LLC | $24.06 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1153460567 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $13.18 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.